Walgreens launches next-day prescription delivery; AbbVie halts trial for cancer drug bought for $10.2 billion; Bill introduced in Senate to penalize pharma for gaming Medicaid.
News
4 startups outline their vision for the future of health tech in 2019
Investment in digital health companies shattered all existing records during 2018 — and startups in the behavioral health area snagged a good deal of it.
Open Health and Peloton Advantage form trans-Atlantic healthcare comms giant
UK-based Open Health has merged with medical comms specialist Peloton Advantage to create a global healthcare communications giant that has 520 staff across seven locations.
Five things for pharma marketers to know: Wednesday, December 5, 2018
CVS draws up plan to pass rebates to clients; Takeda shareholders approve Shire deal; Uber brings on two health executives.
Ogilvy names global creative lead to replace Tham Khai Meng
The WPP agency has also appointed a new chief creative officer for the U.S.
Focus on drugs’ cost may prevent their discovery
Breakthrough drugs will eventually be more affordable, but a misplaced focus on their cost may prevent them from being discovered at all.
How the pharma industry may be impacted by drug pricing and other policies in 2019
Now that the political climate lends itself to action on drug pricing, the days of pharma nirvana may be coming to an end. Here’s a look at the policy considerations likely to vex the industry in the year ahead.
AbelsonTaylor’s Amanda Hartzmark on martial arts, career lessons learned, and how she starts her day
Amanda Hartzmark is director of business development and analysis at AbelsonTaylor.
Five things for pharma marketers to know: Tuesday, December 4, 2018
Novartis hives treatment moves to late-stage trial; Amgen multiple myeloma antibody gets fast-tracked by FDA; ResMed to buy Propeller Health.
Want to read more?
Please login or register first to view this content.
